The ARID1B Phenotype: What We Have Learned so Far

被引:82
|
作者
Santen, Gijs W. E. [1 ]
Clayton-Smith, Jill [1 ]
机构
[1] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands
关键词
Coffin-Siris syndrome; ARID1B; review; CHROMATIN-REMODELING COMPLEX; COFFIN-SIRIS SYNDROME; SWI/SNF COMPLEX; MUTATIONS; DELETION; CANCER; HAPLOINSUFFICIENCY; AGENESIS; PATIENT; REGION;
D O I
10.1002/ajmg.c.31414
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Evidence is now accumulating from a number of sequencing studies that ARID1B not only appears to be one of the most frequently mutated intellectual disability (ID) genes, but that the range of phenotypes caused by ARID1B mutations seems to be extremely wide. Thus, it is one of the most interesting ID genes identified so far in the exome sequencing era. In this article, we review the literature surrounding ARID1B and attempt to delineate the ARID1B phenotype. The vast majority of published ARID1B patients have been ascertained through studies of Coffin-Siris syndrome (CSS), which leads to bias when documenting the frequencies of phenotypic features. Additional observations of those individuals ascertained through exome sequencing studies helps in delineation of the broader clinical phenotype. We are currently establishing an ARID1B consortium, aimed at collecting ARID1B patients identified through genome-wide sequencing strategies. We hope that this endeavor will eventually lead to a more comprehensive view of the ARID1B phenotype. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:276 / 289
页数:14
相关论文
共 50 条
  • [21] De novo splice site variant of ARID1B associated with pathogenesis of Coffin-Siris syndrome
    Pranckeniene, Laura
    Siavriene, Evelina
    Gueneau, Lucie
    Preiksaitiene, Egle
    Mikstiene, Violeta
    Reymond, Alexandre
    Kucinskas, Vaidutis
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (12):
  • [22] ARID1B mutations are the major genetic cause of corpus callosum anomalies in patients with intellectual disability
    Mignot, Cyril
    Moutard, Marie-Laure
    Rastetter, Agnes
    Boutaud, Lucile
    Heide, Solveig
    Billette, Thierry
    Doummar, Diane
    Garel, Catherine
    Afenjar, Alexandra
    Jacquette, Aurelia
    Lacombe, Didier
    Verloes, Alain
    Bole-Feysot, Christine
    Nitschke, Patrick
    Masson, Cecile
    Faudet, Anne
    Lesne, Fabien
    Bienvenu, Thierry
    Alby, Caroline
    Attie-Bitach, Tania
    Depienne, Christel
    Nava, Caroline
    Heron, Delphine
    BRAIN, 2016, 139
  • [23] ARID1B alterations identify aggressive tumors in neuroblastoma
    Lee, Soo Hyun
    Kim, Jung-Sun
    Zheng, Siyuan
    Huse, Jason T.
    Bae, Joon Seol
    Lee, Ji Won
    Yoo, Keon Hee
    Koo, Hong Hoe
    Kyung, Sungkyu
    Park, Woong-Yang
    Sung, Ki W.
    ONCOTARGET, 2017, 8 (28) : 45943 - 45950
  • [24] Papillary thyroid cancer in a patient with interstitial 6q25 deletion including ARID1B
    Vengoechea, Jaime
    Carpenter, Lori
    Zarate, Yuri A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (07) : 1857 - 1859
  • [25] Reply: ARID1B mutations are the major genetic cause of corpus callosum anomalies in patients with intellectual disability
    Edwards, Timothy J.
    Sherr, Elliott H.
    Barkovich, A. James
    Richards, Linda J.
    BRAIN, 2016, 139
  • [26] The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome
    van der Sluijs, Pleuntje J.
    Jansen, Sandra
    Vergano, Samantha A.
    Adachi-Fukuda, Miho
    Alanay, Yasemin
    AlKindy, Adila
    Baban, Anwar
    Bayat, Allan
    Beck-Woedl, Stefanie
    Berry, Katherine
    Bijlsma, Emilia K.
    Bok, Levinus A.
    Brouwer, Alwin F. J.
    van der Burgt, Ineke
    Campeau, Philippe M.
    Canham, Natalie
    Chrzanowska, Krystyna
    Chu, Yoyo W. Y.
    Chung, Brain H. Y.
    Dahan, Karin
    De Rademaeker, Marjan
    Destree, Anne
    Dudding-Byth, Tracy
    Earl, Rachel
    Elcioglu, Nursel
    Elias, Ellen R.
    Fagerberg, Christina
    Gardham, Alice
    Gener, Blanca
    Gerkes, Erica H.
    Grasshoff, Ute
    van Haeringen, Arie
    Heitink, Karin R.
    Herkert, Johanna C.
    den Hollander, Nicolette S.
    Horn, Denise
    Hunt, David
    Kant, Sarina G.
    Kato, Mitsuhiro
    Kayserili, Hulya
    Kersseboom, Rogier
    Kilic, Esra
    Krajewska-Walasek, Malgorzata
    Lammers, Kylin
    Laulund, Lone W.
    Lederer, Damien
    Lees, Melissa
    Lopez-Gonzalez, Vanesa
    Maas, Saskia
    Mancini, Grazia M. S.
    GENETICS IN MEDICINE, 2019, 21 (06) : 1295 - 1307
  • [27] Aberrant cytoplasmic localization of ARID1B activates ERK signaling and promotes oncogenesis
    Animireddy, Srinivas
    Kavadipula, Padmavathi
    Kotapalli, Viswakalyan
    Gowrishankar, Swarnalata
    Rao, Satish
    Bashyam, Murali Dharan
    JOURNAL OF CELL SCIENCE, 2021, 134 (04)
  • [28] Three Novel ARID1B Variations in Coffin-Siris Syndrome Patients
    Tan, Yuxia
    Chen, Jun
    Li, Yutang
    Liu, Yedan
    Wang, Yu
    Xia, Shungang
    Chen, Liping
    Wei, Wei
    Chen, Zongbo
    NEUROLOGY INDIA, 2022, 70 (05) : 2174 - 2179
  • [29] DNA Sequencing of Cancer: What Have We Learned?
    Chmielecki, Juliann
    Meyerson, Matthew
    ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 : 63 - 79
  • [30] A novel microduplication of ARID1B: Clinical, genetic, and proteomic findings
    Seabra, Catarina M.
    Szoko, Nicholas
    Erdin, Serkan
    Ragavendran, Ashok
    Stortchevoi, Alexei
    Maciel, Patricia
    Lundberg, Kathleen
    Schlatzer, Daniela
    Smith, Janice
    Talkowski, Michael E.
    Gusella, James F.
    Natowicz, Marvin R.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (09) : 2478 - 2484